Indication
Liver Transplantation
6 clinical trials
6 products
1 drug
Clinical trial
Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV VaccineStatus: Completed, Estimated PCD: 2016-02-01
Product
Quadrivalent HPV vaccineClinical trial
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant PatientsStatus: Recruiting, Estimated PCD: 2024-06-30
Product
PitavastatinProduct
PCSK9 inhibitorClinical trial
Safety and Preliminary Efficacy of Donor-derived Regulatory Dendritic Cell (DCreg) Infusion and Immunosuppression Withdrawal in Living Donor Liver TransplantationStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Safety and Preliminary Efficacy of Delayed Donor-derived Regulatory Dendritic Cell (DCreg) Infusion and Immunosuppression Withdrawal in Living Donor Liver Transplant (LDLT) RecipientsStatus: Active (not recruiting), Estimated PCD: 2026-06-01
Product
Donor-derived DCregClinical trial
Pharmacodynamics, Pharmacogenomics, and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus in Pediatric Intestinal Transplantation (IND # 100496)Status: Completed, Estimated PCD: 2014-11-01
Drug
alemtuzumabClinical trial
A 12-Month, Open-Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Siplizumab as Induction Therapy in Patients With Autoimmune Liver Diseases Undergoing Liver Transplantation (SET-SAIL)Status: Not yet recruiting, Estimated PCD: 2025-12-31
Product
Siplizumab